1. Introduction {#sec1}
===============

Paragonimiasis is a food-borne illness of the lung caused by trematodes of the genus *Paragonimus.* Humans can become infected with this lung fluke after consuming raw or undercooked freshwater crustaceans. Before infecting mammalian hosts, *Paragonimus* species require a snail as the first intermediate host, and a freshwater crab or crayfish as the second intermediate host. In mammalian definitive hosts, the infective metacercariae excyst in the duodenum and migrate to the lungs, causing pulmonary paragonimiasis, with respiratory symptoms (e.g. coughing) that mimic tuberculosis ([@bib18]). Ectopic paragonimiasis occurs when flukes migrate internally, causing damage to muscles and organs, including the brain (cerebral paragonimiasis) ([@bib3]). *Paragonimus* spp. infect more people globally than any other foodborne trematode, and infections cause an estimated 196,710 disability adjusted life-years ([@bib7]). These estimates do not account for infections in Africa.

*Paragonimus* spp. is best known from Asia and Latin America ([@bib7]). However, two known species, *Paragonimus africanus* and *P. uterobilaterlis*, infect humans in Africa ([@bib3]). *Paragonimus uterobilateralis* is considered the principal causative agent of paragonimiasis in Nigeria ([@bib2]). The epidemiology of *Paragonimus* sp. infections in Nigeria is tightly bound to post-colonial history. Prior to the Biafran war in Nigeria (1967--1970), paragonimiasis was known only from a handful of cases ([@bib13; @bib14]). During the war, food shortages and limited access to cooking facilities led to increased consumption of inadequately cooked or raw crab, and cases of paragonimiasis increased dramatically ([@bib15]). Human infections nearly disappeared again after the war, until recent surveys revealed unexpected high prevalence (up to 13.2%) in communities in the Southeast part of Nigeria ([@bib2]). The epidemiology of *Paragonimus* sp. in Nigeria differs from that in Cameroon, where the disease has a longer history of endemicity due to the cultural practice of eating raw crabs in some areas ([@bib21]).

The African civet (*Viverra civetta*) is considered the natural host of *P. uterobilateralis* in Nigeria ([@bib20]), with the swamp mongoose (*Atilax paludinosus*) and domestic dog (*Canis familiaris*) harboring the parasite in Cameroon and Liberia, respectively ([@bib19]). *Paragonimus africanus* has a broader host range, infecting the mongoose (*Crossarchus obscurus*), palm civet (*Nandinia binotata*), drill monkey (*Mandrillus leucophaeus*), potto (*Perodicticus potto*), and domestic dog (*C. familiaris*) in Cameroon ([@bib19; @bib16]). The intermediate and definitive hosts of *P. africanus* range throughout the contiguous forest of southeastern Nigeria bordering Cameroon ([@bib10; @bib1]), suggesting that *P. africanus* could be more widely distributed than is currently appreciated.

We report the discovery of *Paragonimus* sp. eggs in red-capped mangabeys (*Cercocebus torquatus*) in Nigeria. We sequenced *Paragonimus* sp. DNA directly from eggs in feces to identify it to species and compare it to parasites reported in human populations. We also made observations of primate hosts for clinical signs of infection. Finally, we examined clinical observational data prior to and following treatment of the study population with anthelminthic drugs. We use this information to assess the presence of *Paragonimus* sp. in red-capped mangabeys in Nigeria, the role of these primates as potential hosts, and the clinical effects of the parasite on monkeys.

2. Materials and methods {#sec2}
========================

Between May and August 2012, we collected fecal samples and recorded coughing opportunistically from a group of 49 \[23 adults/sub-adults (≥3 yo) and 12 juveniles (\<3 yo)\] individually identifiable red-capped mangabeys that lived in a 1-ha open topped forest enclosure within the natural home range of the species ([Fig. 1](#fig1){ref-type="fig"}). The population was provisioned daily, but also had access to wild foods within the enclosure. The animals had access to water *ad libitum*, from a natural stream that ran through the enclosure. They were exposed to natural predators (e.g. snakes and birds of prey) and parasites. All animals were rescued from the bushmeat and pet trades in Nigeria as young juveniles, or were captive-born. Thirteen individuals were moved from a sancutary to the open-topped enclosure in 2004 as part of the rehabilitation and release program of the Centre for Education, Research and Conservation of Primates and Nature (CERCOPAN), and the remaining 36 individuals were born in the enclosure.

For 30 days in late May and June 2012, we collected triplicate fecal samples from each individual. Then, in late June 2012, the population was treated for *Paragonimus* sp. via orally administered praziquantel (approximately 20 mg/kg for three consecutive days). We collected subsequent triplicate fecal samples from each individual over 30 days post-treatment, for a total of 294 samples (147 pre-treatment and 147 post-treatment). Over the same time periods (30 days pre-treatment and 30 days post-treatment), we recorded all observed instances of coughing between 6:00 and 17:00 daily. The Institutional Animal Care and Use Committee at University of Wisconsin, Madison approved all research activities (protocol v1490).

Fecal samples were collected from known individuals immediately following defecation, stored temporarily in plastic bags, and fixed within 2 h of collection. We removed two aliquots from each sample for preservation of gastrointestinal parasite eggs and DNA separately. One aliquot was fixed in 10% formalin for microscopic analysis, and the other in RNA*later*^®^ nucleic acid stabilizing solution for genetic analysis. Samples were transported to the University of Wisconsin, Madison following all applicable import, export, and International Air Transport Association regulations. One gram of formalin-preserved feces was concentrated by sedimentation and examined microscopically at X10 and X40 magnification ([@bib8]). We calculated prevalence (percent of individuals infected) as number of individuals shedding eggs divided by the total number of individuals examined, and we approximated mean and median intensity of infection (number of eggs per gram (epg) of a particular parasite species in the feces of a single infected host) ([@bib4; @bib8]). We calculated pre- and post-treatment intensity by taking the average epg of triplicate samples for each individual. We compared *Paragonimus* sp. prevalence and intensity to host characteristics and rates of coughing using Fisher\'s exact test, Mann--Whitney test, and Spearman rank correlation. We then compared parasite intensity and coughing rates pre- and post-treatment using paired Wilcoxon rank sum test. For all pre- and post-treatment comparisons, we used one-tailed tests under the directional hypotheses that coughing frequency would be positively associated with parasite infection.

We extracted DNA from 150 mg of the fecal sample with the highest egg count (1,067 epg) using the Zymo ZR Fecal DNA MiniPrep Kit (Zymo Research Corporation, Irvine, CA, USA), following the manufacturer\'s protocols. PCR and nucleotide sequencing were performed on the internal transcribed spacer 2 region (ITS2) using primers 3S (5′-CGGTGGATCACTCGGCTCGT-3′) and A28 (5′-CCTGGTTAGTTTC TTTTCCTCCGC-3′), previously used to amplify *P. africanus* ([@bib12]). PCR was performed using Phusion High-Fidelity PCR mastermix (New England BioLabs, Ipswich, MA), and cycled in a BioRad CFX96 platform (Bio-Rad Laboratories, Hercules, CA, USA) with the following cycling parameters: 98 °C for 30 min; 40 cycles of 98 °C for 10 s, 55 °C for 30 s, 72 °C for 90 s; and a final extension at 72 °C for 10 min. Amplicons were electrophoresed on an agarose gel stained with ethidium bromide and then purified using the Zymoclean Gel DNA Recovery Kit (Zymo Research Corporation, Irvine, CA, USA). Amplicons were sequenced on ABI 3730xl DNA Analyzers (Applied Biosystems, Grand Island, NY, USA) at the University of Wisconsin--Madison Biotechnology Center DNA Sequencing Facility. Sequences were aligned to published *Paragonimus* sequences using CLUSTAL W ([@bib17]).

3. Results {#sec3}
==========

We recovered parasite eggs that were consistent with *P. africanus* (87.3 ± 7.9 X 45.4 ± 4.5) in 43% of the population. ([Fig. 2](#fig2){ref-type="fig"}). Our DNA sequence (Gen Bank accession number KR780065) was 100% identical to a *P. africanus* sequence from a human in Kumba, Cameroon and 99% identical to another from Bulutu, Cameroon ([@bib12]). Mean intensity prior to treatment was 96.70 epg (95% CI: 29.73--163.67; median = 32.67; range = 1--1067).

We found no association between parasitism (prevalence or intensity) and host sex or age. We recovered *Paragonimus* sp. from animals transferred to the enclosure and those born in the enclosure. We observed 516 coughs in 88% (n = 43) of individuals. Frequency of coughing was over two times higher in *Paragonimus-*positive individuals (μ = 11.42) than in *Paragonimus-*negative individuals (μ = 4.03; W = 192; p \< .02; [Fig. 3](#fig3){ref-type="fig"}a). Coughing frequency also increased with the number of *Paragonimus* sp. eggs shed in feces (rs = .64, p \< .001; [Fig. 3](#fig3){ref-type="fig"}b). De-worming led to a significant reduction in epg (μ = 6.13; p \< .0001; [Fig. 3](#fig3){ref-type="fig"}c) and a corresponding reduction of coughing to baseline levels (μ = 4.95; p \< .01; [Fig. 3](#fig3){ref-type="fig"}d) in infected monkeys.

4. Discussion {#sec4}
=============

We provide the first molecular evidence of *Paragonimus* sp. in African wildlife, and the first report of *Paragonimus* sp. infection in *C. torquatus* and *P. africanus* in Nigerian wildlife. Recent surveys revealing re-emergence of *Paragonimus* sp. in human populations in southeast Nigeria suggest a sylvatic cycle in which the parasite is maintained in crab-eating wildlife reservoirs ([@bib3]). Indeed, *C. torquatus* in Gabon eat crabs as a normal part of the diet ([@bib5]). Our results demonstrate that *C. torquatus* can be a host for *P. africanus*, and infection is associated with respiratory illness. However, given limited sampling and DNA sequencing, we cannot exclude the possibility that this population hosts other species within the genus *Paragonimus*. Together with observations from [@bib23] and [@bib22], these results suggest that wild primates in Nigeria may help maintain *Paragonimus* sp. perhaps contributing to human disease.

Currently, limited genetic data exist for African *Paragonimus* spp. For example, there was no sequence information available for *P. uterobilateralis* on GenBank as of August 7, 2015, and only two sequences from *P. africanus* were available ([@bib12]). Our *P. africanus* sequences were between 99% and 100% identical to sequences from humans in Cameroon, demonstrating only limited intraspecific variation in the ITS2 region of the parasite. *Paragonimus africanus* therefore appears to be genetically homogeneous across Nigeria and Cameroon, albeit based on a limited number of samples and only one genetic locus. *Paragonimus mexicanus,* previously considered the sole etiological agent of paragonimiasis in the Americas, is now believed to include cryptic species ([@bib11]). Further sampling may indicate similar genetic diversity in *P. africanus*.

Significantly, we found that coughing was more frequent in infected individuals, and that animals with more intense infections coughed more frequently. Furthermore, treatment with praziquantel in our study population led to reduced parasite burden and a corresponding reduction of coughing to baseline levels in infected monkeys. Determining whether coughing is communicative or physiological is problematic in studies of primate behavior ([@bib9]). Our results suggest that coughing may actually indicate respiratory disease, such as infection with lung flukes. This observation not only complicates interpretations of primate behavior, but it also suggests a method for clinical assessment of wild primates for paragonimiasis and similar respiratory pathogens. Interestingly, hunters in this area report using primate skulls and feces to treat cough ([@bib6]). In interviews, hunters made reference to seeing monkeys in the area cough as justification for these traditional remedies (S.Friant, unpub.data), indicating an intriguing link between parasitism, clinical disease, local beliefs, and primate conservation.

Knowledge of sylvatic reservoirs will be critical for improved understanding and control of re-emerging paragonimiasis in Nigeria. Given the difficulties associated with eradicating multi-host pathogens, as well as their high potential for emergence and re-emergence, control of paragonimiasis will require not only sustained behavior change away from raw or undercooked crab consumption and improved education, but also surveillance of potential wildlife hosts. In the case of primates, observations of coughing should be considered suspicious for paragonimiasis.
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![**Map of collection site**. Map shows the location of the study population (*black circle*) relative to the Oban Division of Cross River National Park (CRNP), in Cross River State, Nigeria.](gr1){#fig1}

![Microscopic image of *Paragonimus africanus* egg.](gr2){#fig2}

![**Coughing and *Paragonimus* infection**. a) *Paragonimus* infection status and coughs per monkey-month (CPMM) (W = 192; p \< .02), b) intensity of *Paragonimus* infection \[eggs per gram of feces (epg)\] and CPMM (rs = .64, p \< .001), c) de-worming and epg (μ = 6.13; W = 0; p \< .0001), and d) de-worming and CPMM (μ = 4.95; W = 26.5; p \< .01).](gr3){#fig3}
